Letaxaban
Alternative Names: TAK-442Latest Information Update: 05 Nov 2023
At a glance
- Originator Takeda
- Class Antithrombotics; Pyrimidinones
- Mechanism of Action Factor Xa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Acute coronary syndromes; Thromboembolism
Most Recent Events
- 11 May 2011 Discontinued - Phase-II for Acute coronary syndromes in Canada (PO)
- 11 May 2011 Discontinued - Phase-II for Acute coronary syndromes in European Union (PO)
- 11 May 2011 Discontinued - Phase-II for Acute coronary syndromes in India (PO)